Inogen (NASDAQ: INGN) insider transactions
In the twelve months to 10 November 2026, executives and directors of Inogen reported 2 open-market sales of 21,708 shares ($142,519) and 0 open-market purchases, by 1 person, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 September 2026 | Smith Kevin Raymond Merrill | CEO and President | Grant or award | +1,500 | $5.33 | 134,962 | Form 4 |
| 1 September 2026 | Smith Kevin P. | EVP, Bus Dev, GC & Sec | Grant or award | +1,500 | $5.33 | 23,507 | Form 4 |
| 1 September 2026 | Smith Kevin P. | EVP, Bus Dev, GC & Sec | Option exercise | +18,136 | — | 41,643 | Form 4 |
| 1 September 2026 | Smith Kevin P. | EVP, Bus Dev, GC & Sec | Shares withheld for tax | −8,671 | $5.33 | 32,972 | Form 4 |
| 1 September 2026 | Wright Mary E | VP, Chief Accounting Officer | Grant or award | +1,500 | $5.33 | 20,629 | Form 4 |
| 1 July 2026 | Yi Boyer Jennifer M | EVP Entrprs Enblmnt, Ch HR Off | Open-market sale | −10,938 | $6.60 | 5,039 | Form 4 |
| 5 June 2026 | King Kevin M | Director | Grant or award | +28,081 | — | 104,966 | Form 4 |
| 5 June 2026 | Mora Elizabeth | Director | Grant or award | +28,081 | — | 107,261 | Form 4 |
| 5 June 2026 | Rider Heather D. | Director | Grant or award | +28,081 | — | 116,282 | Form 4 |
| 5 June 2026 | Boehnlein Glenn S | Director | Grant or award | +28,081 | — | 104,966 | Form 4 |
| 5 June 2026 | Ladone Mary Kay | Director | Grant or award | +28,081 | — | 104,966 | Form 4 |
| 5 June 2026 | Jamali Vafa | Director | Grant or award | +28,081 | — | 43,081 | Form 4 |
| 5 June 2026 | Sahney Mira Kirti | Director | Grant or award | +28,081 | — | 67,805 | Form 4 |
| 29 May 2026 | Yi Boyer Jennifer M | EVP Entrprs Enblmnt, Ch HR Off | Open-market sale | −10,770 | $6.53 | 15,977 | Form 4 |
| 1 March 2026 | Smith Kevin Raymond Merrill | CEO and President | Grant or award | +685 | $6.10 | 86,976 | Form 4 |
| 1 March 2026 | Smith Kevin Raymond Merrill | CEO and President | Grant or award | +32,725 | — | 119,701 | Form 4 |
| 1 March 2026 | Smith Kevin Raymond Merrill | CEO and President | Shares withheld for tax | −16,374 | $6.10 | 103,327 | Form 4 |
| 1 March 2026 | Smith Kevin Raymond Merrill | CEO and President | Option exercise | +28,334 | — | 131,661 | Form 4 |
| 1 March 2026 | Smith Kevin Raymond Merrill | CEO and President | Shares withheld for tax | −13,700 | $6.10 | 117,961 | Form 4 |
| 1 March 2026 | Smith Kevin Raymond Merrill | CEO and President | Option exercise | +30,012 | — | 147,973 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Inogen page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.